Polyethylene Glycol 4000 for Fecal Disimpaction in Cerebral Palsy Children

Area of Science:

• Pediatric Gastroenterology
• Neurology
• Clinical Pharmacology

Background:

• Constipation and fecal impaction are common in children with cerebral palsy.
• Effective disimpaction strategies are crucial for managing these patients.

Purpose of the Study:

• To evaluate the efficacy of Polyethylene glycol 4000 (PEG 4000) for fecal disimpaction in children with cerebral palsy.
• To compare PEG 4000 with saline enema for treating fecal impaction in this population.

Main Methods:

• A randomized control trial involving 32 children (aged 2-16 years) with cerebral palsy and fecal impaction.
• Participants were assigned to receive either PEG 4000 (0.7 g/kg) or saline enema (15ml/kg) every twelve hours.
• Constipation diagnosed via ROME IV criteria; fecal impaction by abdominal palpation. Efficacy assessed by clinical observation and adverse symptom monitoring.

Main Results:

• PEG 4000 demonstrated significantly faster resolution of fecal impaction compared to saline enema (21.69 hours vs. 39 hours; p=0.001).
• Muscle relaxant use and disease severity did not impact treatment efficacy.
• No adverse symptoms were reported during the treatment period for either group.

Conclusions:

• Polyethylene glycol 4000 is a more rapid and effective treatment for fecal disimpaction in constipated children with cerebral palsy than saline enema.
• PEG 4000 offers a safe and efficient therapeutic option for managing fecal impaction in pediatric cerebral palsy patients.